REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Kordovan Medicina Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: KORDOVAN MEDICINA Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Kordovan Medicina Bt. is a company in Hungary, with a head office in Budapest. It operates in the Pharmacies and Drug Stores industry. It was first established on August 12, 1992. It currently has a total number of 3 (2024) employees. From the latest financial highlights, Kordovan Medicina Bt. reported a net sales revenue increase of 14.03% in 2023. Its’ total assets recorded a growth of 23.25%. Kordovan Medicina Bt.’s net profit margin increased by 1.32% in 2023.

Headquarters
Kordovan ter 1.
Budapest; Budapest; Postal Code: 1046

Contact Details: Purchase the Kordovan Medicina Bt. report to view the information.

Website: http://www.kordovanpatika.hu

Basic Information
Total Employees:
Purchase the Kordovan Medicina Bt. report to view the information.
Outstanding Shares:
Purchase the Kordovan Medicina Bt. report to view the information.
Registered Capital:
Purchase the Kordovan Medicina Bt. report to view the information.
Incorporation Date:
August 12, 1992
Key Executives
Purchase this report to view the information.
Business Manager
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Kordovan Medicina Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
14.03%▲
Total operating revenue
15%▲
Operating profit (EBIT)
46.12%▲
EBITDA
40.3%▲
Net Profit (Loss) for the Period
45.36%▲
Total assets
23.25%▲
Total equity
33.26%▲
Operating Profit Margin (ROS)
1.47%▲
Net Profit Margin
1.32%▲
Return on Equity (ROE)
4.66%▲
Quick Ratio
1.18%▲
Cash Ratio
1.1%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo